Ocugen (OCGN) EBT Margin (QoQ) (2022 - 2026)

Ocugen (OCGN) EBT Margin (QoQ) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Ocugen 399.60 Mn 399.60 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.17 Mn
Dec 31, 2025 1.04 Mn
Sep 30, 2025 39,783.00
Jun 30, 2025 -42,325.00
Mar 31, 2025 78,098.00
Dec 31, 2024 -68,204.00
Sep 30, 2024 69,648.00
Jun 30, 2024 -2,389.00
Mar 31, 2024 698,088.00
Dec 31, 2023 -834,015.00
Sep 30, 2023 535,161.00
Jun 30, 2023 -64,916.00
Mar 31, 2023 -266,256.00
Dec 31, 2022 220,839.00
Sep 30, 2022 -48,190.00
Jun 30, 2022 247,720.00